NTLA Competitors & Alternatives
Compare Intellia Therapeutics Inc with similar stocks in the same industry
Biotechnology
NTLA
Main Stock$13.19
Tradestie Score
29
Market Cap
$2.01B
Revenue Growth
-0.5%
Analyst Upside
+81.5%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$19.46
|
$2.02B | - | 44 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.72
|
$1.97B | - | 55 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.77
|
$1.92B | - | 39 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$95.08
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$71.36
|
$1.90B | 50.4 | 64 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$36.82
|
$1.84B | - | 43 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$37.12
|
$1.81B | - | 32 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$12.24
|
$1.78B | - | 36 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$26.36
|
$1.78B | - | 49 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$150.06
|
$1.77B | - | 42 | Compare |
More NTLA Analysis
Data updated: Aug 26, 2026 | Industry: Biotechnology (SIC 2835)
241 stocks in this industry